Sumitomo Chemical Company, Limited (TYO:4005)
Japan
· Delayed Price · Currency is JPY | Market Cap | 825.57B |
| Revenue (ttm) | 2.41T |
| Net Income (ttm) | 97.37B |
| Shares Out | 1.64B |
| EPS (ttm) | 59.47 |
| PE Ratio | 8.48 |
| Forward PE | 44.02 |
| Dividend | 15.00 (2.98%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 7,130,300 |
| Average Volume | 10,598,140 |
| Open | 503.60 |
| Previous Close | 504.20 |
| Day's Range | 501.10 - 510.30 |
| 52-Week Range | 325.80 - 620.60 |
| Beta | 0.45 |
| RSI | 46.30 |
| Earnings Date | May 14, 2026 |
About Sumitomo Chemical Company
Sumitomo Chemical Company, Limited engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma. The Agro & Life Solutions segment offers crop protection chemicals, fertilizers, agricultural materials, household insecticides, products for control of infectious diseases, and feed additives, etc. The ICT & Mobility Solutions segment provides optical products, semiconductor processing materials, compound semiconductor materials, touch screen sensor panels, high-purity alum... [Read more]
Financial Performance
Financial StatementsNews
Sumitomo Chemical Company Earnings Call Transcript: Q3 2026
Core operating income and net income rose sharply year-on-year, driven by strong pharma sales and divestiture gains, despite lower sales revenue. FY2025 guidance was raised, with a higher dividend payout and improved outlook for semiconductors, but Q4 non-recurring losses are expected.
Samsung Electro-Mechanics Signs MOU with Sumitomo Chemical Group to Establish a Joint Venture for 'Glass Core' Used in Package Substrates
Strengthening strategic cooperation for next-generation semiconductor package core material 'Glass Core' Aiming to lead the glass substrate market by combining strengths in preparation for the AI era ...
Sumitomo Chemical Company Earnings Call Transcript: Q2 2026
Core operating income and net profit rose sharply year-over-year, led by pharma and divestitures, despite lower sales revenue. Full-year guidance was raised for core profit, but the outlook remains cautious amid persistent low petrochemical margins and global uncertainty.
Shares of Asian drugmakers drop after Trump threatens tariffs
Shares of Asian drugmakers mostly fell on Friday after U.S. President Donald Trump threatened 100% tariffs on imports of branded pharmaceuticals from October 1, unless their producers had already brok...
Sumitomo Chemical Company Transcript: Status Update
Management is prioritizing core businesses in organic synthesis, crop protection, and advanced materials, while expanding into regenerative medicine and cell therapy. Financial targets include improved capital efficiency and shareholder returns, with ongoing structural reforms and a focus on innovation to stay competitive.
Sumitomo Chemical Company Earnings Call Transcript: Q1 2026
First quarter FY2025 saw improved core operating income and segment profitability, despite lower sales revenue and a net loss driven by foreign exchange impacts. Outlook for the first half remains positive, with strong shipments and one-time gains expected to support results.
Chloroethane Global Market Insights 2025, Analysis and Forecast to 2030, with Profiles of Westlake, Sumitomo Chemical, and Lanxess
Chloroethane Market Growth: Discover trends in the chloroethane market driven by advancements in coatings, plastics, and gasoline additives. This volatile organic compound thrives on high-purity produ...
Middle East and Africa Electric Vehicle Battery Separator Market Forecast Report 2025-2030, with Key Player Profiles for Entek, Toray, Sinoma, UBE, Celgard, Sumitomo Chemical & Abu Dhabi Polymers
Key drivers include rising EV adoption and falling lithium-ion battery costs, with significant growth anticipated in the UAE. Key drivers include rising EV adoption and falling lithium-ion battery cos...
Sumitomo Chemical Company Earnings Call Transcript: Q4 2025
Core operating income rebounded sharply in FY 2024, driven by improved segment performance and asset sales, with net income and free cash flow turning positive. FY 2025 guidance anticipates higher profits despite lower revenue, amid FX and tariff headwinds.
Sumitomo Chemical Company Transcript: Status Update
Management targets a V-shaped earnings recovery, focusing investments on Agro and ICT growth drivers, with robust structural reforms and a shift toward environmental and healthcare solutions. Financial discipline, enhanced governance, and digital transformation underpin the plan.
Sumitomo Chemical Company Earnings Call Transcript: Q3 2025
Q3 FY2024 saw a strong turnaround with core operating income and net income both sharply higher year-on-year, driven by Pharma and ICT & Mobility. Full-year guidance is unchanged, with segment forecasts adjusted for market and operational factors.
Sumitomo Chemical Company Earnings Call Transcript: Q2 2025
Core operating income saw a strong V-shaped recovery, driven by IT-related Chemicals and near-elimination of Pharma losses, despite a net loss from one-off factors. The company raised its cash generation target, advanced structural reforms, and expects further improvement in FY 2025.
Aluminum Hydroxide Industry Business Report 2023-2030 with Focus on 40+ Select Players Including Aluminum Corp of China, J.M. Huber, Nabaltec, Showa Denko, Sumitomo Chemical, & The R.J.
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Aluminum Hydroxide - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Aluminum Hydrox...